Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea

A. Barceló, J. Piérola, M. de la Peña, C. Esquinas, A. Fuster, M. Sánchez, M. Carrera, A. Alonso-Fernández, A. Ladaria, M. Bosch, F. Barbé (Palma de Mallorca, Madrid, Lleida, Spain)

Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Session: Obesity: positive effects of bariatric surgery and exercise
Session type: E-Communication Session
Number: 5268
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Barceló, J. Piérola, M. de la Peña, C. Esquinas, A. Fuster, M. Sánchez, M. Carrera, A. Alonso-Fernández, A. Ladaria, M. Bosch, F. Barbé (Palma de Mallorca, Madrid, Lleida, Spain). Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea. Eur Respir J 2010; 36: Suppl. 54, 5268

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea
Source: Eur Respir J 2011; 37: 1418-1423
Year: 2011



Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012

Association between obstructive sleep apnea and nonalcoholic fatty liver disease
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019

The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease.
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease.
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019

The relationship between uric acid levels and mean platelet volume and metabolic syndrome in males with with obstructive sleep apnoea syndrome
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012


Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2004 - Systemic and metabolic effects from OSA
Year: 2004


Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009

The influence on hyperlipemia and abnormal glucose metabolism in obstructive sleep apnea-hypopnea syndrome (OSAHS)
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 332s
Year: 2004

Metabolic syndrome in obstructive sleep apnea: prevalence and correlation with metabolic abnormalities
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009


Metabolic syndrome in obstructive sleep apnea: prevalence and correlation with metabolic abnormalities
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Plasma orexin-A levels in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


Effect of arterial hypertension, obesity and overnight desaturation on plasma uric acid concentration in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012


Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009


Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


APAP impact on metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Plasma antioxidant factors in persons with different stages of obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 564s
Year: 2004